Cardiac Issues Associated with High-Dose Drug Trial

Last week, Teva Pharmaceutical Industries Ltd. and Active Biotech AB announced they were ending the higher-dose portions of two multiple-sclerosis medication studies. The decision came after eight patients suffered nonfatal… Read More

New Zealand Students Seek to Improve Food Packaging

New Zealand students recently addressed the difficulties faced by the elderly and disabled when it comes to food packaging. Whangarei MP Dr. Share Reti, the parliamentary facilitator for Arthritis New… Read More

Premature Babies to Benefit from 3-D Printing Technology

We spoke with Zintro expert Scott Bork in August about the FDA approval of Spritam, the first 3D printed drug, designed to treat seizures brought on by epilepsy in children… Read More

Drugmakers and Insurers Attempt to Collaborate on Medication Prices

An increasing number of drugmakers, including Biogen Inc., Amgen Inc., and Sanofi are taking a proactive marketing approach–talking with insurers about costly medications still under development. With the price of these… Read More